The Effect of Curcumin on Blood Glucose Patients with Type 2 Diabetes Mellitus: A Systematic Review

Article Preview

Abstract:

Type 2 Diabetes Mellitus (DM) is characterized by elevated blood glucose. Curcumin has glucose-lowering properties. This review intended to determine if Curcumin can lower blood glucose levels in type 2 diabetic patients. This review intended to determine if Curcumin can decrease blood glucose in type 2 DM patients. Curcumin has a mechanism of stimulating incretin and inhibiting digestive enzymes from reducing blood glucose levels in type 2 DM patients. We systematically searched PubMed for peer-reviewed studies examining the mechanism of Curcumin in decreasing blood glucose in type 2 DM patients. The journal criteria included in this review were a study from 2000 to 2022, randomized control trial using intervention Curcumin, an outcome variable using blood glucose, the full text of the article can be obtained, and the DM patient's age is over 18 years. Two independent reviewers retrieved data o clinical outcomes, studies, and patient characteristics using the Cochrane Risk of Bias Assessment Instrument. Quality is evaluated using the Grading of Recommendations Assessment, Development, and Evaluation system. There are 19 studies included in this research, and Three journals meet the requirements. The conclusion is that curcumin can decrease blood glucose in Type 2 DM patients.

You might also be interested in these eBooks

Info:

Pages:

91-100

Citation:

Online since:

November 2023

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2023 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] C.P. Gobert, A.M. Duncan. Consumption, Perceptions and Knowledge of Soy among Adults with Type 2 Diabetes. Journal of the American College of Nutrition (2009);28(2):203-218

DOI: 10.1080/07315724.2009.10719772

Google Scholar

[2] C. Jiang shi, L. Liang fu, Y. Guo wei. Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades. Acta Pharmacol Sin (2012);33(10):1217-1245.

DOI: 10.1038/aps.2012.90

Google Scholar

[3] M.J. Page, J.E. McKenzie, P.M. Bossuyt, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (2021):n71.

Google Scholar

[4] J. Belur, L. Tompson, A. Thornton, M. Simon. Interrater Reliability in Systematic Review Methodology: Exploring Variation in Coder Decision-Making. Sociological Methods & Research (2021);50(2):837-865.

DOI: 10.1177/0049124118799372

Google Scholar

[5] M. Funamoto, K. Shimizu, Y. Sunagawa, et al. Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus. Journal of Diabetes Research (2019); 2019:1-7.

DOI: 10.1155/2019/8208237

Google Scholar

[6] A.F.G. Cicero, A. Sahebkar, F. Fogacci, M. Bove, M. Giovannini, C. Borghi. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. Eur J Nutr (2020);59(2):477-483.

DOI: 10.1007/s00394-019-01916-7

Google Scholar

[7] R. Shafabakhsh, Z. Asemi, Z. Reiner, A. Soleimani, E. Aghadavod, F. Bahmani. The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomized, Double Blind, Placebo-controlled Trial. Iran J Kidney Dis (2020); 4(4): 290-299.

DOI: 10.1039/c8fo00888d

Google Scholar

[8] M. Mokhtari, R. Razzaghi, M. Momen‐Heravi. The effects of curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double‐blind, placebo‐controlled trial. Phytotherapy Research. 2021;35(4):2099-2107.

DOI: 10.1002/ptr.6957

Google Scholar

[9] L.X. Na, Y. Li, H.Z. Pan, et al. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res. 2013; 57(9):1569-1577.

DOI: 10.1002/mnfr.201200131

Google Scholar

[10] S. Asadi, M.S. Gholami, F. Siassi, M. Qorbani, K. Khamoshian, G. Sotoudeh. Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial. Complementary Therapies in Medicine. 2019; 43: 253-260.

DOI: 10.1016/j.ctim.2019.02.014

Google Scholar

[11] A. Shehzad, T. Ha, F. Subhan, Y.S. Lee. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr (2011); 50(3):151-161.

DOI: 10.1007/s00394-011-0188-1

Google Scholar

[12] S. Chuengsamarn, S. Rattanamongkolgul, R. Luechapudiporn, C. Phisalaphong, S. Jirawatnotai. Curcumin Extract for Prevention of Type 2 Diabetes. Diabetes Care (2012);35(11):2121-2127.

DOI: 10.2337/dc12-0116

Google Scholar

[13] P. Murugan, L. Pari. Influence of Tetrahydrocurcumin on Hepatic and Renal Functional Markers and Protein Levels in Experimental Type 2 Diabetic Rats. Basic Clin Pharmacol Toxicol (2007);101(4):241-245.

DOI: 10.1111/j.1742-7843.2007.00109.x

Google Scholar

[14] M.A. El-Moselhy, A. Taye, S.S. Sharkawi, S.F.I. El-Sisi, A.F. Ahmed. The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-α and free fatty acids. Food and Chemical Toxicology (2011);49(5):1129-1140.

DOI: 10.1016/j.fct.2011.02.004

Google Scholar

[15] M.B. Chougala, J.J. Bhaskar, M.G.R. Rajan, P.V. Salimath. Effect of curcumin and quercetin on lysosomal enzyme activities in streptozotocin-induced diabetic rats. Clinical Nutrition (2012);31(5):749-755.

DOI: 10.1016/j.clnu.2012.02.003

Google Scholar

[16] N.A. Prabowo, H. Apriningsih. Colchicine reduces the degree of inflammation in COVID-19 patients. IOP Conf Ser: Earth Environ Sci (2021);824(1):012087.

DOI: 10.1088/1755-1315/824/1/012087

Google Scholar

[17] N.A. Prabowo, R.H. Setyaningrum, H. Apriningsih. Interleukin 6 Associated with Adrenal Insufficiency in COVID-19 Patient. MJMHS (2022):4.

Google Scholar

[18] N.A. Prabowo, Z.A. Adnan, A. Nurudhin, Y. Werdiningsih, K. Prasetyo. Mesenchymal Stem Cell Conditioned Medium as Good as Methyl Prednisolone in Decreasing Levels of Interleukin 10 and The Degree of Pulmonary Vasculitis in Lupus Mice. Bangladesh J Med Sci (2021); 20(2): 426-430.

DOI: 10.3329/bjms.v20i2.51560

Google Scholar

[19] N.A. Prabowo, R. Myrtha, H. Apriningsih. Lupus Flares in COVID-19 Patients: A Case Report. MJMHS (2022):3.

Google Scholar

[20] M. Chanpoo, H. Petchpiboonthai, B. Panyarachun, V. Anupunpisit. Effect of curcumin in the amelioration of pancreatic islets in streptozotocin-induced diabetic mice. J Med Assoc Thai (2010); 93 Suppl 6:S152-159.

Google Scholar

[21] M.V. Walvekar, N.D. Potphode, S.S. Desai, V.M. Deshmukh. Histological studies on islets of langerhans of pancreas in diabetic mice after curcumin administration. Int J Pharm Clin Res (2016).

Google Scholar

[22] M.T. Abdel Aziz, M.F. El-Asmar, A.M. Rezq, et al. The effect of a novel curcumin derivative on pancreatic islet regeneration in experimental type-1 diabetes in rats (long term study). Diabetol Metab Syndr (2013);5(1):75.

DOI: 10.1186/1758-5996-5-75

Google Scholar

[23] R. Ganugula, M. Arora, P. Jaisamut, et al. Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus: nCUR to manage Type 1 diabetes mellitus. British Journal of Pharmacology (2017);174(13):2074-2084.

DOI: 10.1111/bph.13816

Google Scholar

[24] S. Shome, A.D. Talukdar, M.D. Choudhury, M.K. Bhattacharya, H. Upadhyaya. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective. Journal of Pharmacy and Pharmacology (2016);68(12):1481-1500.

DOI: 10.1111/jphp.12611

Google Scholar

[25] Y. Zanzer, Â. Batista, A. Dougkas, J. Tovar, Y. Granfeldt, E. Östman. Difficulties in Translating Appetite Sensations Effect of Turmeric-Based Beverage When Given Prior to Isoenergetic Medium- or High-Fat Meals in Healthy Subjects. Nutrients (2019);11(4):736.

DOI: 10.3390/nu11040736

Google Scholar

[26] M. Kato, S. Nishikawa, A. Ikehata, et al. Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion. Mol Nutr Food Res (2017);61(3):1600471.

DOI: 10.1002/mnfr.201600471

Google Scholar